ArticleVeterinary medicine international2026
Endemic Persistence of Bovine Leukemia Virus in aHigh-Producing Brazilian Dairy Herd: Seroprevalence Across Production Strata, Vertical Transmission, and Mortality Risk.
Article in Veterinary medicine international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine leukemia virus (BLV) is globally distributed and remains difficult to control. The infection is associated with substantial economic losses resulting from reduced productivity and early culling. Seroepidemiological studies conducted in Brazil have demonstrated that BLV prevalence rates range from 18.30% to 46.76%, with prevalence estimates reaching up to 90% in Goiás State, where the present study was performed. This study investigates the silent epidemiological persistence of BLV in a high-producing dairy herd, highlighting category-specific seroprevalence patterns, serological evidence suggestive of possible vertical exposure, and the association between BLV seropositivity and mortality. A total of 570 Girolando females were divided into the following groups for analysis of anti-BLV antibodies: multiparous (I), primiparous (II), bred nulliparous heifers (III), and nonbred heifers (IV). We performed the analysis using a commercial enzyme-linked immunosorbent assay. Our research group evaluated the impact of BLV seropositivity on milk yield (MY), somatic cell count (SCC), services per conception (SC), and calving interval (CI). In addition, serological evidence suggestive of possible vertical exposure and herd incidence rates were assessed during a 3-month follow-up period. Prevalence of BLV seropositivity was 59.82% (95% CI: 55.75%-63.77%). Cows in Group I showed a significantly higher likelihood of seropositivity than those in Group IV, with an approximately 8.6-fold (95% CI: 4.96-15.03) increased risk of BLV seropositivity. Serological findings suggestive of possible vertical exposure were detected in 13.59% of the evaluated neonates, and the BLV incidence rate in the herd was 34.06 new seropositive cases over the 3-month follow-up period. Despite the high seroprevalence observed in the herd, no adverse effects were associated with productive or reproductive parameters. No significant association was observed between BLV seropositivity and lymphocytosis (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.